Kewaunee Scientific Corporation KEQU
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 1.71M | 3.39M | 692.00K | 2.45M | 3.09M |
| Total Depreciation and Amortization | 1.59M | 1.56M | 1.60M | 1.58M | 1.55M |
| Total Amortization of Deferred Charges | 56.00K | 57.00K | 322.00K | 94.00K | 94.00K |
| Total Other Non-Cash Items | 619.00K | 852.00K | 951.00K | -339.00K | 897.00K |
| Change in Net Operating Assets | -2.00M | -392.00K | 8.09M | -8.05M | 158.00K |
| Cash from Operations | 1.98M | 5.46M | 11.65M | -4.27M | 5.79M |
| Capital Expenditure | -772.00K | -928.00K | -668.00K | -1.57M | -771.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -772.00K | -928.00K | -668.00K | -1.57M | -771.00K |
| Total Debt Issued | 17.80M | 1.62M | 21.41M | 2.21M | 1.38M |
| Total Debt Repaid | -18.74M | -4.57M | -35.13M | -2.39M | -2.84M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -1.56M | 0.00 | 0.00 | -671.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | -339.00K | -- | -- |
| Cash from Financing | -2.50M | -2.95M | -14.06M | -853.00K | -1.46M |
| Foreign Exchange rate Adjustments | -61.00K | -312.00K | -251.00K | -74.00K | -280.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.36M | 1.27M | -3.33M | -6.76M | 3.28M |